Form D · Other
LabLabee Inc.
New York, NY · CIK 0001981994
Offering snapshot reported Jun 4, 2024 · SEC filing
- Reported sold
- $3.42M Offering amount: $3.56M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 4, 2024 | Initial | $3,423,143 | No comparison | 8 | SEC filing |
| Jul 18, 2023 | Amendment | $0 | $0vs Jun 20, 2023 | 16 | SEC filing |
| Jun 20, 2023 | Initial | $0 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-515126
$150,000.00 of the Total Offering Amount represents the conversion of outstanding principal under a simple agreement for future equity.
Source: Form D, filed Jun 4, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nabil Chair | Executive, Promoter |
| Mahfoud Mebareki | Executive, Promoter |
| Mahfoud Sidi Ali Mebarek | Director, Promoter |
| Esteban Sosnik | Director |
| Samir Tahraoui | Director, Executive, Promoter |
Issuer details
Industry: Other (See others in industry)
Address:
C/O Orbiss 1411 Broadway
New York, NY, 10018
New York, NY, 10018